HCAT - Health Catalyst - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HCAT is currently covered by 14 analysts with an average price target of $7.79. This is a potential upside of $4.04 (107.73%) from yesterday's end of day stock price of $3.75.

Health Catalyst's activity chart (see below) currently has 153 price targets and 153 ratings on display. The stock rating distribution of HCAT is 74.51% BUY and 25.49% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.28% with an average time for these price targets to be met of 96.39 days.

Highest price target for HCAT is $16, Lowest price target is $4, average price target is $9.42.

Most recent stock forecast was given by DAVID LARSEN from BTIG on 17-Jun-2025. First documented stock forecast 19-Aug-2019.

Currently out of the existing stock ratings of HCAT, 38 are a BUY (74.51%), 13 are a HOLD (25.49%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$20

9 days ago
(17-Jun-2025)

0/5 (0%)

$5.68 (39.66%)

Buy

$9

$5.4 (150.00%)

$10

1 months 18 days ago
(08-May-2025)

4/13 (30.77%)

$4.82 (115.31%)

96

Hold

$5.5

$1.9 (52.78%)

$5

1 months 18 days ago
(08-May-2025)

3/10 (30%)

$1.32 (31.58%)

57

Buy

$6.5

$2.9 (80.56%)

$10

2 months 1 days ago
(25-Apr-2025)

3/11 (27.27%)

$2.4 (58.54%)

269

Buy

$5

$1.4 (38.89%)

$9

2 months 10 days ago
(16-Apr-2025)

0/4 (0%)

$1.25 (33.33%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HCAT (Health Catalyst) average time for price targets to be met?

On average it took 96.39 days on average for the stock forecasts to be realized with a an average price target met ratio 33.28

Which analyst has the current highest performing score on HCAT (Health Catalyst) with a proven track record?

STEVEN HALPER

Which analyst has the most public recommendations on HCAT (Health Catalyst)?

Steven Halper has 9 price targets and 6 ratings on HCAT

Which analyst is the currently most bullish on HCAT (Health Catalyst)?

Sandy Draper with highest potential upside - $50.22

Which analyst is the currently most reserved on HCAT (Health Catalyst)?

David Larsen with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?